Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HAART-treated”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00056797
What this trial is testing

Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 92
Post-approval studies (Phase 4)Study completedNCT00615810
What this trial is testing

ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation Trial

Who this might be right for
HIV Infections
Gilead Sciences 159
Early research (Phase 1)Study completedNCT00796770
What this trial is testing

Vaccination of HIV-1 Infected Patients With Dendritic Cells in Addition to Antiretroviral Treatment - (DALIA Trial)

Who this might be right for
HIV
Baylor Research Institute 19
Post-approval studies (Phase 4)Study completedNCT00940771
What this trial is testing

Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens

Who this might be right for
Pediatric HIVHIV Infections
Phoenix Children's Hospital 10
Testing effectiveness (Phase 2)Study completedNCT00751595
What this trial is testing

Immunogenicity and Safety Trial of the HIV-1 Tat Vaccine

Who this might be right for
HIV Infections
Barbara Ensoli, MD 168
Not applicableStudy completedNCT00001131
What this trial is testing

Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 42
Not applicableUnknownNCT01344148
What this trial is testing

Acquired Immunodeficiency Syndrome(AIDS) and Tuberculosis(Tb) Co-infection Treatment Strategies Study of China.

Who this might be right for
AIDS
Shanghai Public Health Clinical Center 400
Not applicableStudy completedNCT01038076
What this trial is testing

Medications for Chronic HIV: Education and Collaboration

Who this might be right for
HIV InfectionsAcquired Immunodeficiency SyndromeMedication Adherence
Boston University 371
Testing effectiveness (Phase 2)Study completedNCT00031343
What this trial is testing

The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and Ribavirin

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 128
Early research (Phase 1)Study completedNCT01546818
What this trial is testing

Safety and Immune Response Assessment Study of Killed-whole HIV-1 Vaccine (SAV001-H) in Chronic HIV-1 Infected Patients

Who this might be right for
HIV Infections
Sumagen 33
Not applicableStudy completedNCT01286259
What this trial is testing

Short-term Disulfiram Administration to Accelerate the Decay of the HIV Reservoir in Antiretroviral-treated HIV Infected Individuals

Who this might be right for
HIV-1 Infection
University of California, San Francisco 16
Testing effectiveness (Phase 2)Study completedNCT00987948
What this trial is testing

Maraviroc Intensification and Peripheral Blood Monocyte HIV DNA Levels

Who this might be right for
HIV Infections
University of Hawaii 15
Not applicableStudy completedNCT00013871
What this trial is testing

Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs

Who this might be right for
HIV InfectionsHepatitis BMeasles+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 300
Large-scale testing (Phase 3)UnknownNCT03037372
What this trial is testing

Statin Adjunct Therapy Among ART-treated Adults in Sub-Saharan Africa: Atorvastatin and Rosuvastatin Equivalence Trial

Who this might be right for
HIV Infection
Makerere University 320
Early research (Phase 1)Study completedNCT00056758
What this trial is testing

HIV Vaccine Designed for HIV Infected Adults Taking Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 18
Post-approval studies (Phase 4)Ended earlyNCT00100984
What this trial is testing

A 48 Week Study Comparing Treatment With Saquinavir + Lopinavir/Ritonavir in Combination With Enfuvirtide HAART Versus Saquinavir + Lopinavir/Ritonavir + Other Nucleoside Combinations to See the Efficacy of These Treatments in Patients Infected With HIV-1

Who this might be right for
HIV Infection
Hoffmann-La Roche 8
Post-approval studies (Phase 4)Study completedNCT00531557
What this trial is testing

Double Protease Inhibitor to Darunavir Switch Study

Who this might be right for
HIV Infections
St Stephens Aids Trust 12
Early research (Phase 1)UnknownNCT00517569
What this trial is testing

Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients

Who this might be right for
HIV Infections
Genexine, Inc. 12
Post-approval studies (Phase 4)Study completedNCT00487188
What this trial is testing

Evaluate the Safety and Efficacy of Adding Enfuvirtide to Oral Highly Active Antiretroviral Therapy (HAART) in Human Immunodeficiency Virus (HIV) Patients With Prior Treatment Experience

Who this might be right for
HIV Infections
Hoffmann-La Roche 47
Post-approval studies (Phase 4)Study completedNCT00960622
What this trial is testing

Switch From Combivir or Trizivir to Truvada - Mitochondrial Effects

Who this might be right for
HIV
St. Luke's-Roosevelt Hospital Center 17
Next Page